|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Xenotech, MultiCell Technologies Inc. (MUCL) Licensee, Presents Cell Lines At 7th Annual ISSX Meeting
10/19/2005 5:10:33 PM
MultiCell Technologies, Inc. (OTCBB:MUCL) announced today that XenoTech LLC, MultiCell's marketing and manufacturing licensee, is presenting MultiCell's immortalized liver cell lines at the 7th Annual International Society for the Study of Xenobiotics Meeting in Vancouver, Canada August 29 to Sept. 2. Dr. Andrew Parkinson, CEO, Kammie Settle, Marketing and Customer Service Manager, Jeff Shannon, Services Support Specialist, Maciej Czerwinski, Ph.D., Senior Scientist, and other key XenoTech personnel are present. XenoTech is featuring MultiCell's Fa2n-4 and EA1C-35 immortalized human hepatocyte lines at Booth 211. XenoTech's Japanese distributor, Nosan, also has personnel at the booth.
|
|
|
|
|
|
|
|
|
|
|